• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

366例匈牙利系统性硬化症患者的生存情况及死因

Survival and causes of death in 366 Hungarian patients with systemic sclerosis.

作者信息

Czirják L, Kumánovics G, Varjú C, Nagy Z, Pákozdi A, Szekanecz Z, Szucs G

机构信息

University of Pécs, Medical School, Department of Immunology and Rheumatology, H-7621 Pécs, Hungary.

出版信息

Ann Rheum Dis. 2008 Jan;67(1):59-63. doi: 10.1136/ard.2006.066340. Epub 2007 May 22.

DOI:10.1136/ard.2006.066340
PMID:17519276
Abstract

OBJECTIVE

Survival analysis of a series of 366 consecutive patients with systemic sclerosis (SSc).

METHODS

Clinical and laboratory data were evaluated from 1983 until 2005 using a standard protocol. The female/male ratio was 315/51. The mean (SD) age of the patients was 56.8 (12.2) years. The duration of disease was 12 (5-19) years with a median follow-up of 6 (3-12) years.

RESULTS

Kaplan-Meier univariate analysis showed that renal, cardiac involvement, pigmentation disturbances, malabsorption, a forced vital capacity <50%, diffuse scleroderma, presence of early malignancy, anaemia, and increased erythrocyte sedimentation rate (ESR) were signs of unfavourable prognosis, whereas anti-centromere antibodies were indicators of a good survival. In the multivariate Cox proportional hazards model the presence of diffuse scleroderma, renal involvement, coexistence of a malignant disease, and increased ESR were poor independent prognostic signs. Elderly age at the onset of disease also caused an unfavourable outcome. A total of 86 SSc-related deaths were recorded during the follow-up. Of them, 65% were attributed to cardiorespiratory manifestation of disease. Tumour associated early death was found in 12 cases (14%).

CONCLUSIONS

In addition to the well-known factors influencing the outcome (diffuse subset, internal organ involvements, and inflammatory signs), the coexistence of scleroderma with a malignancy also causes a poor outcome.

摘要

目的

对连续366例系统性硬化症(SSc)患者进行生存分析。

方法

采用标准方案对1983年至2005年期间的临床和实验室数据进行评估。女性/男性比例为315/51。患者的平均(标准差)年龄为56.8(12.2)岁。病程为12(5 - 19)年,中位随访时间为6(3 - 12)年。

结果

Kaplan - Meier单因素分析显示,肾脏、心脏受累、色素沉着紊乱、吸收不良、用力肺活量<50%、弥漫性硬皮病、早期恶性肿瘤、贫血以及红细胞沉降率(ESR)升高是预后不良的征象,而抗着丝点抗体是生存良好的指标。在多变量Cox比例风险模型中,弥漫性硬皮病、肾脏受累、恶性疾病并存以及ESR升高是不良的独立预后征象。疾病发病时年龄较大也导致不良结局。随访期间共记录了86例与SSc相关的死亡病例。其中,65%归因于疾病的心肺表现。12例(14%)发现与肿瘤相关的早期死亡。

结论

除了影响预后的众所周知的因素(弥漫性亚型、内脏器官受累以及炎症征象)外,硬皮病与恶性肿瘤并存也会导致不良结局。

相似文献

1
Survival and causes of death in 366 Hungarian patients with systemic sclerosis.366例匈牙利系统性硬化症患者的生存情况及死因
Ann Rheum Dis. 2008 Jan;67(1):59-63. doi: 10.1136/ard.2006.066340. Epub 2007 May 22.
2
Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.在西班牙系统性硬化症患者中与死亡率相关的生存、死因和危险因素:来自一家大学医院的结果。
Semin Arthritis Rheum. 2010 Feb;39(4):285-93. doi: 10.1016/j.semarthrit.2009.06.002. Epub 2009 Sep 25.
3
Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study.泰国早期系统性硬化症患者的死亡原因、生存情况和死亡风险因素:一项发病队列研究。
Rheumatol Int. 2017 Dec;37(12):2087-2094. doi: 10.1007/s00296-017-3846-7. Epub 2017 Oct 12.
4
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.多发性硬化症发病队列的早期死亡率。
Arthritis Rheumatol. 2017 May;69(5):1067-1077. doi: 10.1002/art.40027. Epub 2017 Apr 6.
5
Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.临床特征、血清抗核抗体及肺功能对系统性硬化症患者生存率的影响。
J Rheumatol. 2001 Nov;28(11):2454-9.
6
Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis.
Clin Exp Rheumatol. 2005 Mar-Apr;23(2):165-72.
7
Predictors of survival in 171 patients with systemic sclerosis (scleroderma).171例系统性硬化症(硬皮病)患者的生存预测因素。
Clin Rheumatol. 1997 Sep;16(5):454-60. doi: 10.1007/BF02238937.
8
Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival.系统性硬皮病重叠综合征中的自身抗体及其与器官损害和生存的相关性。
Ann Med. 2024 Dec;56(1):2407526. doi: 10.1080/07853890.2024.2407526. Epub 2024 Sep 30.
9
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.系统性硬化症的生存和预后因素:一项法国多中心队列研究、系统评价和文献荟萃分析的数据。
Arthritis Res Ther. 2019 Apr 3;21(1):86. doi: 10.1186/s13075-019-1867-1.
10
Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.C 反应蛋白与系统性硬化症高疾病活动度的相关性:来自加拿大硬皮病研究组的研究结果。
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.

引用本文的文献

1
Cancer in connective tissue disease.结缔组织病中的癌症。
Front Immunol. 2025 May 9;16:1571700. doi: 10.3389/fimmu.2025.1571700. eCollection 2025.
2
Malignancy in Systemic Sclerosis: A Multicenter Retrospective Study.系统性硬化症中的恶性肿瘤:一项多中心回顾性研究。
Biomedicines. 2025 Apr 19;13(4):993. doi: 10.3390/biomedicines13040993.
3
Microstomia is associated with functional impairment and is a poor prognostic factor in systemic sclerosis - a single center observational study with survival analysis.小口畸形与功能障碍相关,并且是系统性硬化症的预后不良因素——一项带有生存分析的单中心观察性研究。
BMC Oral Health. 2024 Nov 15;24(1):1390. doi: 10.1186/s12903-024-05178-6.
4
Prevalence and gender - specific analysis of a systemic sclerosis cohort in Latvia.拉脱维亚系统性硬化症队列的流行率和性别特异性分析。
Orphanet J Rare Dis. 2024 Sep 30;19(1):361. doi: 10.1186/s13023-024-03355-y.
5
Association between neutrophil/lymphocyte ratio and disease severity in scleroderma patients.硬皮病患者中性粒细胞/淋巴细胞比值与疾病严重程度之间的关联。
Heliyon. 2023 Sep 30;9(10):e20576. doi: 10.1016/j.heliyon.2023.e20576. eCollection 2023 Oct.
6
Ultrasound abnormalities of the major salivary glands in Egyptian patients with systemic sclerosis.埃及系统性硬化症患者主要唾液腺的超声异常。
Clin Rheumatol. 2023 Dec;42(12):3351-3360. doi: 10.1007/s10067-023-06763-w. Epub 2023 Sep 18.
7
Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.硬皮病患者的 ScleroID 特征强调了肌肉骨骼和内脏器官的影响。
Arthritis Res Ther. 2023 May 20;25(1):84. doi: 10.1186/s13075-023-03063-1.
8
Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.贫血是系统性硬化症患者器官损害轨迹恶化的一个指标:一项回顾性研究。
J Clin Med. 2022 Aug 26;11(17):5013. doi: 10.3390/jcm11175013.
9
Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study.瑞典系统性硬化症患者的生存情况:一项全国范围内基于人群的匹配队列研究。
Rheumatology (Oxford). 2023 Mar 1;62(3):1170-1178. doi: 10.1093/rheumatology/keac474.
10
Repolarization in systemic sclerosis: a meta-analysis.系统性硬化症中的复极:一项荟萃分析。
Clin Rheumatol. 2022 Apr;41(4):1131-1137. doi: 10.1007/s10067-021-05996-x. Epub 2021 Nov 29.